Fuyang people's hospital
10
3
4
1
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
20%
2 trials in Phase 3/4
0%
0 of 1 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
Role: collaborator
Intravascular Ultrasound- and Angiography-Derived Fractional Flow Reserve-Guided Drug-Coated Balloon for Large Coronary Artery De Novo Lesions
Role: collaborator
Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT)
Role: collaborator
Simultaneous Vs Staged VPS and CP :A Multi-cnter RCT.
Role: collaborator
Ultrasound Large-scale Model in Thyroid Field: A Multi-center Study on Medical-Engineering Integration
Role: collaborator
Hemoadsorption for Severe Ischemic Stroke
Role: collaborator
The Preventive Effect of Shenfu Injection on Myocardial Dysfunction in Sepsis
Role: collaborator
Early Pancreatic Stent Placement for Preventing PEP
Role: collaborator
Calculator Predicts Early Mortality Post Hepatocellular Carcinoma Resection
Role: collaborator
LISA vs INSURE in the Treatment of Respiratory Distress Syndrome in Preterm Infants
Role: collaborator
All 10 trials loaded